Hepatocellular Carcinoma and Sex Hormones
Author Information
Author(s): Naofumi Nagasue, Hitoshi Kohno
Primary Institution: Shimane Medical University
Hypothesis
What is the genuine role of sex hormones in hepatocarcinogenesis in experimental animals and particularly in humans?
Conclusion
Human hepatocellular carcinomas seem to be more androgen-dependent, and hormone therapy may improve survival rates in patients with HCC.
Supporting Evidence
- Hepatocellular carcinoma is more prevalent in men than in women.
- Long-term use of oral contraceptives can induce liver tumors.
- Some HCCs may be androgen dependent, while others may be estrogen dependent.
- Withdrawal of oral contraceptives can induce regression of drug-induced hepatic tumors.
- High titers of progesterone receptor are present in benign liver tumors but not in HCC.
Takeaway
This study looks at how sex hormones affect liver cancer, showing that men are more likely to get it and that hormones might help treat it.
Methodology
The study reviewed existing literature and analyzed hormone receptor presence in HCC patients.
Potential Biases
Potential bias in the selection of studies reviewed and the interpretation of hormone receptor data.
Limitations
Limited evidence for a direct etiologic relationship between androgenic steroids and HCC in humans.
Participant Demographics
107 patients with hepatocellular carcinoma, with a predominance of males.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website